Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iPro Pathogen Protection is a Canadian product development, manufacturing, and wholesale distribution company focused on pathogen-protection, sanitization, and disinfection products. The company markets commercial products such as hand sanitizer, fabric and surface protectors, and hospital-grade disinfectant/cleaner formulations for healthcare, care homes, workplaces, transportation, veterinary, education, and other institutional settings. Public materials describe its products as alcohol-free or long-lasting in certain use cases and emphasize oxygen-based disinfection and molecular bonding nanotechnology for extended surface protection. iPro appears to be a commercial-stage operating business rather than a drug-development biotech, with activity centered on infection-prevention products rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iPro Pathogen Protection.